0001650664-24-000076.txt : 20240606
0001650664-24-000076.hdr.sgml : 20240606
20240606161711
ACCESSION NUMBER: 0001650664-24-000076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240604
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Gilmore Neil
CENTRAL INDEX KEY: 0001742084
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 241025283
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
wk-form4_1717705020.xml
FORM 4
X0508
4
2024-06-04
0
0001650664
Editas Medicine, Inc.
EDIT
0001742084
O'Neill Gilmore Neil
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
1
1
0
0
CEO
1
Common Stock
2024-06-04
4
S
0
12191
5.4956
D
315279
D
Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.
/s/ Gilmore O'Neill
2024-06-06